Apimeds Pharmaceuticals US, Inc. trades by members of Congress

Purchases and sales of Apimeds Pharmaceuticals US, Inc. shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

No member of Congress has disclosed a trade in Apimeds Pharmaceuticals US, Inc. in the reports filed since January 3, 2015. See the latest trades by members of Congress.

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to Apimeds Pharmaceuticals US, Inc. · Insider trading · Funds · All trades by members of Congress